Improvements to managing medicine shortages and discontinuations

Interruptions to the supply and availability of medicines in Australia can occur for various reasons and have a range of impacts on patients and health professionals. Medicine shortages are a global problem and unfortunately some supply disruptions can be unavoidable.

We continually seek out ways to improve the way we monitor and reduce the impact of shortages and discontinuations in Australia. Recent improvements include the introduction of the medicine shortages data-sharing framework, which allows us to share information to better manage serious shortages of hospital medicines. However, medicine shortages can still impact the health and wellbeing of people in Australia.

In 2024, we heard about the challenges and barriers people currently experience associated with medicine shortages and discontinuations. In response, we are pursuing a program of regulatory, digital and process improvements to address the following high priority issues and further reduce the impact of medicine supply disruptions:

1. Update TGA’s medicine shortages regulatory framework to better meet public information needs – this is our initial focus.
2. Critical data and digital infrastructure improvements.
3. Better access to shortages information for health professionals.
4. Better sponsor predictions on medicine demand and shortages.

Updating TGA’s medicine shortages regulatory framework to better meet public information needs

Health professionals and consumers need access to timely and accurate information about medicine shortages and discontinuations to effectively plan and manage their response to a supply disruption. We heard that there is a need for earlier notice of discontinuations to support health professionals and consumers in adapting to changes in available therapies.

We also heard that certain medicines considered essential to the health of consumers are not currently captured in the mandatory reporting framework. For these medicines, the TGA has limited powers to require the pharmaceutical companies who supply them (sponsors) to provide detailed supply information when a possible shortage or supply disruption occurs.

In late 2024, we asked for feedback on proposed changes to the medicine shortages and discontinuations regulatory framework to:

• Add critical non-prescription medicines to the list of reportable medicines, which would require sponsors of those medicines to report shortages and discontinuations to the TGA.
• Update the Therapeutic Goods Act 1989 to enable the TGA to require detailed supply information from sponsors of any medicines, not just reportable medicines.
• Update the Therapeutic Goods Act 1989 to require sponsors to provide 12 months’ notice to the TGA of a decision to permanently discontinue supply of any reportable medicine in Australia. 

The TGA has reviewed and considered all the feedback received on the proposals.

In early 2025, we added 25 additional medicines to the legislative instrument that lists non-prescription reportable medicines. This means that sponsors of these medicines are required to report shortages and discontinuations to the TGA. The list of reportable non-prescription medicines can be found at:

• Therapeutic Goods (Reportable Medicines) Determination 2025.

We will continue to update this page with information about these proposals. Please note, amendments to the Therapeutic Goods Act 1989 are subject to Australian Government consideration. 

Further information on how to report shortages and discontinuations to the TGA is available at Reporting a shortage or discontinuation of a medicine you supply.

Investigating other improvements

We are also investigating other possible improvements to:

• further reduce the impact of shortages and discontinuations through uplift of data and digital infrastructure
• improve the accessibility of shortages information for health professionals to better empower their decisions and minimise consumer impact
• assist medicine sponsors in making predictions on the demand for their medicines, leading to more accurate information on the TGA website about the length of a shortage and the dates that a medicine will return to supply.